Cumberland Advisors’s Merck MRK Stock Holding History

Cumberland Advisors’s Portfolio MRK Stock Details MRK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-3,585	Closed	-$275K	–	63
2021 Q4	$275K	Hold	3,585	–	–	0.06%	58
2021 Q3	$269K	Hold	3,585	–	–	0.06%	56
2021 Q2	$279K	Sell	3,585 -3,316	-48%	-$247K	0.07%	58
2021 Q1	$508K	Hold	6,901	–	–	0.13%	52
2020 Q4	$539K	Buy	+6,901	New	+$528K	0.2%	46
2020 Q2	$339K	Hold	4,595	–	–	0.13%	53
2020 Q1	$337K	Hold	4,595	–	–	0.14%	52
2019 Q4	$399K	Hold	4,595	–	–	0.14%	56
2019 Q3	$369K	Hold	4,595	–	–	0.1%	61
2019 Q2	$368K	Sell	4,595 -105	-2%	-$8.04K	0.12%	61
2019 Q1	$373K	Hold	4,700	–	–	0.13%	58
2018 Q4	$343K	Buy	+4,700	New	+$332K	0.12%	55

Other funds holding MRK

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Cumberland Advisors's MRK Position: Q1 2022 in Review

Cumberland Advisors sold out of Merck (MRK) in Q1 2022, closing a stake of 3,585 shares — an estimated $275K sold.

Cumberland Advisors first reported a position in MRK in Q4 2018 and held it in 12 quarters. The position peaked at $539K in Q4 2020. 2,952 funds tracked by Wall St. Rank hold MRK as of Q1 2022.

Cumberland Advisors reported no remaining Merck position as of Q1 2022 after selling out during the quarter.
Cumberland Advisors sold 3,585 Merck shares in Q1 2022, an estimated $275K.
Cumberland Advisors first reported a position in Merck in Q4 2018 and held it in 12 quarters.
Cumberland Advisors's Merck position peaked at $539K in Q4 2020.
2,952 funds tracked by Wall St. Rank held Merck as of Q1 2022.

Based on Cumberland Advisors's 13F filing for Q1 2022, filed 19 Apr 2022.